Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew B Lassman

Showing results (31-40 of 145) with videos related to

Pageof 15
Sort By:
JCO Oncology Practice|April 29, 2025
Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline Rapid Recommendation Update Clinical InsightsNimish A Mohile, Andrew B Lassman, David Schiff, et al.
Gynecologic Oncology|February 11, 2010
Paraneoplastic opsoclonus-myoclonus syndrome secondary to immature ovarian teratomaEmil Lou, Martee L Hensley, Andrew B Lassman, et al.
Neuro-Oncology|April 30, 2025
Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline Rapid Recommendation UpdateJaishri Blakeley, Nimish A Mohile, Hans Messersmith, et al.
Journal of Neuro-Oncology|March 7, 2013
Steroid management in newly diagnosed glioblastomaMariel B Deutsch, Katherine S Panageas, Andrew B Lassman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2025
Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline Rapid Recommendation UpdateJaishri Blakeley, Nimish A Mohile, Hans Messersmith, et al.
Neuro-Oncology Advances|July 16, 2020
Current usage of tumor treating fields for glioblastomaAndrew B Lassman, Adela E Joanta-Gomez, Peter C Pan, et al.
Journal of Neuro-Oncology|February 11, 2010
High dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancerJennifer L Clarke, William Pao, Nian Wu, et al.
Neuron Glia Biology|October 19, 2006
Overexpression of c-MYC promotes an undifferentiated phenotype in cultured astrocytes and allows elevated Ras and Akt signaling to induce gliomas from GFAP-expressing cells in miceAndrew B Lassman, Chengkai Dai, Gregory N Fuller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 26, 2011
Seizures and radionecrosis from non-small-cell lung cancer presenting as increased fluorodeoxyglucose uptake on positron emission tomographyPatrick G Morris, Philip H Gutin, Edward K Avila, et al.
Journal of Neuro-Oncology|September 18, 2012
Abbreviated course of radiation therapy with concurrent temozolomide for high-grade glioma in patients of advanced age or poor functional statusMarsha Reyngold, Andrew B Lassman, Timothy A Chan, et al.
Pageof 15

Showing results (31-40 of 145) with videos related to

Sort By:
Pageof 15
JCO Oncology Practice|April 29, 2025
Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline Rapid Recommendation Update Clinical InsightsNimish A Mohile, Andrew B Lassman, David Schiff, et al.
Gynecologic Oncology|February 11, 2010
Paraneoplastic opsoclonus-myoclonus syndrome secondary to immature ovarian teratomaEmil Lou, Martee L Hensley, Andrew B Lassman, et al.
Neuro-Oncology|April 30, 2025
Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline Rapid Recommendation UpdateJaishri Blakeley, Nimish A Mohile, Hans Messersmith, et al.
Journal of Neuro-Oncology|March 7, 2013
Steroid management in newly diagnosed glioblastomaMariel B Deutsch, Katherine S Panageas, Andrew B Lassman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2025
Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline Rapid Recommendation UpdateJaishri Blakeley, Nimish A Mohile, Hans Messersmith, et al.
Neuro-Oncology Advances|July 16, 2020
Current usage of tumor treating fields for glioblastomaAndrew B Lassman, Adela E Joanta-Gomez, Peter C Pan, et al.
Journal of Neuro-Oncology|February 11, 2010
High dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancerJennifer L Clarke, William Pao, Nian Wu, et al.
Neuron Glia Biology|October 19, 2006
Overexpression of c-MYC promotes an undifferentiated phenotype in cultured astrocytes and allows elevated Ras and Akt signaling to induce gliomas from GFAP-expressing cells in miceAndrew B Lassman, Chengkai Dai, Gregory N Fuller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 26, 2011
Seizures and radionecrosis from non-small-cell lung cancer presenting as increased fluorodeoxyglucose uptake on positron emission tomographyPatrick G Morris, Philip H Gutin, Edward K Avila, et al.
Journal of Neuro-Oncology|September 18, 2012
Abbreviated course of radiation therapy with concurrent temozolomide for high-grade glioma in patients of advanced age or poor functional statusMarsha Reyngold, Andrew B Lassman, Timothy A Chan, et al.
Pageof 15